GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Lifotronic Technology Co Ltd (SHSE:688389) » Definitions » ROC %

Shenzhen Lifotronic Technology Co (SHSE:688389) ROC % : 29.59% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shenzhen Lifotronic Technology Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Shenzhen Lifotronic Technology Co's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was 29.59%.

As of today (2025-03-30), Shenzhen Lifotronic Technology Co's WACC % is 12.89%. Shenzhen Lifotronic Technology Co's ROC % is 37.84% (calculated using TTM income statement data). Shenzhen Lifotronic Technology Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Shenzhen Lifotronic Technology Co ROC % Historical Data

The historical data trend for Shenzhen Lifotronic Technology Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Lifotronic Technology Co ROC % Chart

Shenzhen Lifotronic Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC %
Get a 7-Day Free Trial 32.13 39.58 43.39 33.70 37.78

Shenzhen Lifotronic Technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.04 63.54 43.34 22.61 29.59

Shenzhen Lifotronic Technology Co ROC % Calculation

Shenzhen Lifotronic Technology Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=354.471 * ( 1 - 4.94% )/( (824.518 + 959.513)/ 2 )
=336.9601326/892.0155
=37.78 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1820.516 - 170.009 - ( 931.641 - max(0, 368.047 - 1194.036+931.641))
=824.518

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2331.379 - 241.114 - ( 1309.598 - max(0, 525.265 - 1656.017+1309.598))
=959.513

Shenzhen Lifotronic Technology Co's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=326.124 * ( 1 - -7.18% )/( (1014.411 + 1348.291)/ 2 )
=349.5397032/1181.351
=29.59 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2415.482 - 226.796 - ( 1332.627 - max(0, 550.108 - 1724.383+1332.627))
=1014.411

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2823.07 - 223.48 - ( 1734.681 - max(0, 870.22 - 2121.519+1734.681))
=1348.291

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Lifotronic Technology Co  (SHSE:688389) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Shenzhen Lifotronic Technology Co's WACC % is 12.89%. Shenzhen Lifotronic Technology Co's ROC % is 37.84% (calculated using TTM income statement data). Shenzhen Lifotronic Technology Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Shenzhen Lifotronic Technology Co ROC % Related Terms

Thank you for viewing the detailed overview of Shenzhen Lifotronic Technology Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Lifotronic Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Qiuzhi East Road, Guanhu Street, 1st Floor, Jindi Tianyue Bay, Guancheng Community, Longhua District, Guangdong, Shenzhen, CHN, 518055
Shenzhen Lifotronic Technology Co Ltd is a China based company engaged in the development, production and sales of therapeutic and rehabilitation products, in vitro diagnostic equipment and supporting reagents.
Executives
Wang Zheng Core technical personnel
Peng Guo Qing Core technical personnel
Xiang Lei Director
Wang Hong Director
Hu Ming Long Director
Li Da Wei senior management

Shenzhen Lifotronic Technology Co Headlines

No Headlines